Botox vs. Nabota: The Comparison Guide
Reviewed for medical accuracy against our Medical Review Board · Last updated 15 August 2026
Part of Botox vs Other Neurotoxin Brands
You may already have had Nabota without realising it, in the US it is sold under a different name entirely.
Botox and Nabota are both botulinum toxin type A treatments used to reduce the appearance of facial wrinkles and treat certain medical conditions. While Botox is the most well-known and widely used, Nabota (also known as Jeuveau in the U.S.) is gaining popularity as a newer and more affordable alternative.
In this in-depth guide, we’ll compare Botox and Nabota in terms of composition, efficacy, cost, onset, safety, and more, so you can make an informed decision with your provider.
1. Understanding Botox and Nabota
1.1 Definitions and Origins
Botox (OnabotulinumtoxinA): Botox was developed by Allergan and has become a household name. It was first approved by the FDA in 1989 for medical uses such as strabismus (crossed eyes) and blepharospasm (eyelid spasms), and later in 2002 for cosmetic use. Since then, it has been used in millions of treatments around the world.
Nabota (also marketed as Jeuveau): Nabota is a botulinum toxin type A product manufactured by Daewoong Pharmaceutical in South Korea. It was introduced to the U.S. market in 2019 under the brand name Jeuveau. It is the first botulinum toxin developed specifically for aesthetic use and marketed as “#NewTox.”
1.2 Mechanism of Action
Both Botox and Nabota work by inhibiting the release of acetylcholine, a neurotransmitter responsible for muscle contraction. When injected into specific facial muscles, these products reduce activity and allow the skin above to smooth out, significantly improving the appearance of dynamic wrinkles like frown lines, crow’s feet, and forehead lines.
1.3 FDA Approval and Global Use
- Botox: Approved for both cosmetic and therapeutic uses. Therapeutic uses include migraine prevention, treatment for overactive bladder, muscle stiffness, eye muscle disorders, TMJ, and excessive sweating (hyperhidrosis).
- Nabota/Jeuveau: Approved in the U.S. exclusively for cosmetic treatment of moderate to severe glabellar lines. It is widely used off-label for other facial areas and has regulatory approval in multiple countries.
2. How Botox and Nabota diverge
2.A Composition and Purity
- Botox: Contains the active neurotoxin plus complexing proteins. These proteins may increase the risk of antibody development over long-term use, which could reduce effectiveness.
- Nabota: Features a highly purified formulation without accessory proteins, potentially lowering the likelihood of developing resistance. This higher purity may be particularly beneficial for patients receiving repeated treatments over many years.
2.B Indications
| Area | Botox | Nabota (Jeuveau) |
|---|---|---|
| Frown Lines | ✅ | ✅ |
| Forehead Lines | ✅ (off-label) | ✅ (off-label) |
| Crow’s Feet | ✅ (off-label) | ✅ (off-label) |
| TMJ/Migraines | ✅ | ❌ |
| Hyperhidrosis | ✅ | ❌ |
While Botox is versatile for both cosmetic and medical use, Nabota is limited to aesthetic treatment, making it more suitable for patients seeking beauty-only results.
2.C Units and Conversion
- Botox and Nabota units are considered 1:1 equivalent. However, some injectors report slight differences in how the two diffuse within tissue. Nabota may spread slightly differently, which could influence dosage or injection technique depending on the area being treated.
2.D Onset and Duration
- Botox: Results begin to show in 3–5 days, with full effect in about 10–14 days. The average duration is around 3–4 months but may vary by metabolism, lifestyle, and injection site.
- Nabota: Has a comparable onset and peak time. Some studies suggest a slightly faster onset (sometimes noticeable within 2–3 days). Duration is also around 3–4 months, though this can vary with dosage and individual response.
3. Effectiveness in practice
3.A Clinical Trials and Outcomes
- Botox: Supported by over 3,000 clinical studies. Its results are consistently reliable across patient demographics. Botox remains the benchmark by which other botulinum toxins are judged.
- Nabota: Clinical studies such as EVOLUS-001 have shown that Nabota is non-inferior to Botox in efficacy and safety for treating glabellar lines. Many injectors report equally satisfactory outcomes in daily practice.
3.B Aesthetic Results
- Both provide smooth, natural-looking results when injected correctly. Nabota is especially praised for delivering a softer appearance with a slightly faster onset.
- Botox may provide more consistent results for deeper, established lines due to its longer clinical history and dosing protocols. Injector skill and technique remain the most important factors in achieving optimal results.
3.C Long-Term Use
- Botox: Decades of long-term use data have proven its safety, effectiveness, and consistent performance.
- Nabota: Though newer, early data and anecdotal reports suggest reliable long-term results, especially with repeated cosmetic treatments. The high purity may offer reduced risk of desensitization.
4. What each one costs
4.A Cost Per Unit
- Botox: Generally ranges from $12–$20 per unit in the U.S., depending on the provider and region.
- Nabota/Jeuveau: Typically offered at a slightly lower cost, around $8–$16 per unit, making it an attractive option for cost-conscious patients.
4.B Total Treatment Costs
| Area | Botox | Nabota (Jeuveau) |
|---|---|---|
| Frown Lines | $240–$400 | $200–$320 |
| Forehead | $200–$300 | $160–$240 |
| Crow’s Feet | $250–$400 | $200–$320 |
These estimates can vary significantly based on injector expertise, clinic location, and promotional pricing.
5. Side effects and risk
5.A Common Side Effects
- Both Botox and Nabota share a similar profile of mild, temporary side effects such as injection site swelling, redness, bruising, headache, or slight drooping. These typically resolve within days.
5.B Rare Complications
- Rare risks include eyebrow or eyelid ptosis, asymmetry, and muscle weakness. These are usually the result of improper placement or dosing, reinforcing the importance of a skilled injector.
5.C Immunogenicity Risk
- Nabota’s lack of accessory proteins might make it less likely to trigger antibody formation. This is particularly relevant for patients receiving frequent or high-dose injections.
6. Ideal Candidates: Who Should Choose Which?
Botox Is Best For:
- Individuals needing both medical and cosmetic treatment.
- Patients who want a time-tested, research-backed solution.
- Those receiving botulinum toxin injections for the first time who prefer the brand with the longest track record.
Nabota/Jeuveau Is Best For:
- Individuals focused only on aesthetic concerns.
- Cost-sensitive patients looking for effective, wallet-friendly alternatives.
- Regular users seeking a cleaner formulation with lower resistance potential.
Factors to Consider:
- Treatment goals (aesthetic only vs. combined medical + cosmetic).
- Budget and availability.
- Your injector’s comfort and experience with each product.
7. Real-World Use and Practitioner Insights
7.1 What Experts Say
- Botox: Continues to be the most trusted and widely administered botulinum toxin. Its consistency, reputation, and versatility make it a go-to for many professionals.
- Nabota: Highly regarded for aesthetic treatments, especially among clinics offering a modern or youthful brand identity. Its fast results and competitive price make it increasingly popular.
7.2 Patient Feedback
- Many patients report no noticeable difference between the two in terms of visual results or duration.
- Some prefer Nabota for the quick onset, while others remain loyal to Botox for its reliability and familiarity.
7.3 Before-and-After Results
- High-quality before-and-after results can be achieved with either product, provided the injector is experienced.
- Results tend to be most noticeable after 10–14 days.
8. Combination or Rotation Possibilities
8.1 Can You Switch Between Botox and Nabota?
Yes, switching is common and safe. Some injectors recommend alternating products every few sessions to avoid building resistance to any single brand.
8.2 Can You Combine Them?
It’s generally advised to stick with one brand per treatment session to maintain dosing accuracy and consistent results.
8.3 Long-Term Planning
- If you're a frequent user, talk to your provider about long-term rotation strategies.
- Evaluate cost, availability, and effectiveness at each appointment to decide the best fit.
9. Off-Label Use & Market Expansion
| Use Area | Botox | Nabota (Jeuveau) |
|---|---|---|
| Gummy Smile | ✅ | ✅ (off-label) |
| Lip Flip | ✅ | ✅ (off-label) |
| Neck Bands | ✅ | ✅ (off-label) |
| Brow Lift | ✅ | ✅ (off-label) |
| Migraine Relief | ✅ | ❌ |
While Botox has widespread approval for therapeutic applications, Nabota remains limited to aesthetic use but is expanding in popularity worldwide.
10. Decision Guide: Botox or Nabota?
10.1 What to Consider
- Botox: Best for patients who want the most validated treatment with broad applications.
- Nabota: Ideal for patients seeking cosmetic-only solutions, especially if price is a factor.
- Your provider can help match the best product based on your anatomy, goals, and treatment history.
10.2 Consultation Tips
- Ask your injector to explain the pros and cons of both options.
- Inquire about their personal experience using each product.
- Confirm the clinic uses authentic products, especially for newer brands.
10.3 Choosing the Right Provider
- Skill and experience matter more than the product.
- Look for licensed medical professionals with aesthetic injection certification.
- Review before-and-after images, patient testimonials, and ratings.
Final Thoughts: Botox vs. Nabota
Botox and Nabota (Jeuveau) are both excellent choices for reducing dynamic wrinkles and enhancing facial aesthetics. While Botox remains the most studied and widely used, Nabota is an affordable, high-purity alternative that delivers equally impressive cosmetic results.
Your choice should ultimately depend on your goals, budget, and trust in your injector. With the right provider, both Botox and Nabota can help you achieve smoother, more youthful skin with minimal downtime.
The fact that decides this comparison: Nabota has no US approval
We searched the FDA's own drug label database for Nabota on 30 August 2026. There is no US label for it. The same search returns Jeuveau, whose generic name is prabotulinumtoxinA, manufactured by Evolus.
Those are the same molecule. Nabota is the Korean brand name; Jeuveau is the name it is approved and sold under in the United States. So the honest answer to "Botox or Nabota" for a US reader is that Nabota is not a product you can lawfully be treated with here under that name. If a US clinic offers you Nabota, ask what is actually in the syringe and whether it was imported, because an FDA-approved version of that drug exists and is called something else.
Where the comparison does apply, it is Botox against Jeuveau, and the difference is approval breadth rather than the drug. BOTOX Cosmetic holds four cosmetic indications: glabellar lines, lateral canthal lines, forehead lines and platysma bands. Jeuveau holds one, glabellar lines. Both use an identical regimen in that shared area: 4 Units into each of five sites, 20 Units in total.
Our guide to Korean botulinum toxins covers the wider picture of products approved in Korea but not in the United States.
Frequently asked questions
Is Nabota available in the United States?
Not under that name. Nabota is the Korean brand name for the product sold in the US as Jeuveau, and the US approval is the Jeuveau one. So if a US clinic offers you "Nabota", the right question is what is actually in the vial and whether it carries a US NDC number. A product bought under its foreign name and used here has not been through the US approval that Jeuveau has.
Is Nabota the same as Botox?
No. It is a different botulinum toxin type A product from a different manufacturer, with its own potency assay. Every product in this class states in its own label that its units cannot be converted into any other product’s units. They do the same thing by the same mechanism; they are not interchangeable by the numbers.
What does its US approval actually cover?
As Jeuveau, moderate to severe glabellar lines in adults, and nothing else. The label’s boxed warning states explicitly that it is not approved for spasticity or any condition other than glabellar lines, which is a narrower approval than Botox holds.
How good is the evidence behind it?
Two trials enrolling 654 people, randomised three to one, reporting 68% and 70% success against a 1% placebo rate at Day 30, with the improvement scored independently by both the investigator and the patient. That is a real and reasonably strict evidence base. It has never been compared head to head with Botox.
Should I be worried about counterfeit product?
It is the right thing to be careful about, and not because of where a product is made. The FDA has warned publicly about unapproved and counterfeit botulinum toxin administered outside medical settings. Ask to see the vial and its US NDC number before it is mixed, and be wary of foreign-language packaging with no US labelling, or of any injection offered in a home, hotel or salon.
Sources
Every figure on this page was read from the documents below rather than from a clinic or a manufacturer's marketing. They open in a new tab so you can check any claim here against its source.
- BOTOX Cosmetic prescribing information, FDA via DailyMed
- Jeuveau prescribing information, FDA via DailyMed
- FDA drug label record for Jeuveau (prabotulinumtoxinA), no US label exists for Nabota, openFDA, US Food and Drug Administration
